NCT04280172 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Oikarainen A, Mikkonen K, Kenny A, Tomietto M, Tuomikoski AM, Meriläinen M, Miettunen J, Kääriäinen M
Educational interventions designed to develop nurses' cultural competence: A systematic review. Int J Nurs Stud. 2019 Oct;98:75-86. doi: 10.1016/j.ijnurstu.2019.06.005. Epub 2019 Jun 21.
Oikarainen A, Mikkonen K, Tuomikoski AM, Elo S, Pitkänen S, Ruotsalainen H, Kääriäinen M
Mentors' competence in mentoring culturally and linguistically diverse nursing students during clinical placement. J Adv Nurs. 2018 Jan;74(1):148-159. doi: 10.1111/jan.13388. Epub 2017 Aug 1.

Educational Intervention to Support Development of Mentors' Cultural Competence and Competence in Mentoring Culturally and Linguistically Diverse Nursing Students

Details for clinical trial NCT04280172

Clinical trial NCT04280172 - References